The mitochondrial serine protease HtrA2/Omi: An overview

Cell Death and Differentiation

Volumn 15, Issue 3, 2008, Pages 453-460

  Vande Walle, L ^a,b   Lamkanfi, M ^a,b,c   Vandenabeele, P ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CATHEPSIN B; INHIBITOR OF APOPTOSIS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PDZ PROTEIN; PRESENILIN 1; PROTEINASE; SERINE PROTEINASE OMI; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; CELL DEATH; DNA DAMAGE; ENZYME ACTIVITY; HIGH TEMPERATURE; HUMAN; MISSENSE MUTATION; MITOCHONDRION; MUTATION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; HUMANS; MICE; MITOCHONDRIAL PROTEINS; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; NEURODEGENERATIVE DISEASES; PHYLOGENY; SERINE ENDOPEPTIDASES;

MAMMALIA; MUS;

EID: 39449115415     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402291     Document Type: Review

References (99)

1. Clausen T, Southan C, Ehrmann M. The HtrA family of proteases: implications for protein composition and cell late. Mol Cell 2002; 10: 443-455.
2. Pallen MJ, Wren BW. The HtrA family of serine proteases. Mol Microbiol 1997; 26: 209-221.
3. Koonin EV, Aravind L. Origin and evolution of eukaryotic apoptosis: The bacterial connection. Cell Death Differ 2002; 9: 394-404.
4. Sagan L. On the origin of mitosing cells. J Theor Biol 1967; 14 255-274.
5. Jones JM, Datta P, Srinivasula SM, Ji W, Gupta S, Zhang Z et al. Loss of Orni mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 2003; 425: 721-727.
6. Strauss KM, Martins LM, Plun-Favreau H, Marx FP, Kautzmann S, Berg D et al. Loss of function mutations in the gene encoding Orni/HtrA2 in Parkinson's disease. Hum Mol Genet 2005; 14: 2099-2111.
7. Igaki T, Suzuki Y, Tokushige N, Aonuma H, Takahashi R, Miura M. Evolution of mitochondrial cell death pathway: Proapoptotic role of HtrA2/Orni in Drosophilla. Biochem Biophys Res Commun 2007; 356 993-997.
8. Challa M, Malladi S, Pellock BJ, Dresnek D, Varadarajan S, Yin YW et al. Drosophila Orni, a mitochondrial-localized IAP antagonist and proapoptotic serine protease. EMBO J 2007; 26: 3144-3156.
9. Spiess C, Beil A, Ehrmann M. A temparature-dependent switch from chaperone to protease in a widely conserved heat shock protein. Cell 1999; 97: 339-347.
10. Kolmar H, Wallet PR, Sauer RT. The DegP and degQ periplasmic endoproteases of Escherichia coli: Specificity for cleavage sites and substrate conformation. J Bacteriol 1996; 178: 5925-5929.
11. Walsh NP, Alba BM, Bose B, Gross CA, Sauer RT. OMP peptide signals initiate the envelope-stress response by activating DegS protease via relief of inhibition mediated by its PDZ domain. Cell 2003; 113 61-71.
12. Kim DY, Kim DR, Ha SC, Lokanath NK, Lee CJ, Hwang HY et al. Crystal structure of the protease domain of a heat-shock protein HtrA from Thermatoga maritima. J Biol Chem 2003; 278: 6543-6551.
13. Waller PR, Sauer RT. Characterization of degQ and degS, Escherichia coli genes encoding homologs of the DegP protease. J Bacteriol 1996; 178: 1146-1153.
14. Hegde R, Srinivasula SM, Zhang Z, Wassell R, Mukattash R, Cilenti L et al. Identification of Orni/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem 2002; 277: 432-438.
15. Martins LM, Iaccarino I, Tenev T, Gschmeissner S, Totty NF, Lemoine NR et al. The serine protease Orni/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem 2002; 277 439-444.
16. Gray CW, Ward RV, Karran E, Turconi S, Rowles A, Viglienghi D et al Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur J Biochem 2000; 267 5699-5710.
17. Kuninaka S, Iida SI, Hara T, Nomura M, Naoe H, Morisaki T et al. Serine protease Orni/HtrA2 targets WARTS kinase to control cell proliferation. Oncogene 2007; 26: 2395-2406.
18. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R. A serine protease, HtrA2 is released from the mitochondda and interacts with XIAP, inducing cell death. Mol Cell 2001; 8: 613-621.
19. van Loo G, van Gurp M, Depuydt B, Srinivesula SM, Rodriguez I, Alnemri ES et al. The serine protease Orni/HtrA2 Is released from mitochondria during apoptosis. Orni interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ 2002; 9: 20-26.
20. Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM et al. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 2002; 277: 445-454.
21. Savopoulos JW, Carter PS, Turconi S, Pettman GR, Karran EH, Gray CW et al. Expression, purification, and functional analysis of the human serine protease HtrA2. Protein Expr Purif 2000; 19: 227-234.
22. Seong YM, Choi JY, Park HJ, Kim KJ, Ahn SG, Seong GH et al. Autocatalytic processing of HtrA2/Orni is essential for induction of caspase-dependent cell death through antagonizing XIAP. J Biol Chem 2004; 279: 37588-37596.
23. Martins LM, Mordson A, Klupsch K, Fedele V, Moisoi N, Teismann P et al. Neuroprotective role of the Reaper-related serine protease HtrA2/ Orni revealed by targeted deletion in mice. Mol Cell Biol 2004; 24: 9848-9862.
24. Grau S, Richards PJ, Kerr B, Hughes C, Caterson B, Williams AS et al The role of human HtrA1 in arthritic disease. J Biol Chem 2006; 281: 6124-6129.
25. Hu SI, Carozza M, Klein M, Nantermet P, Luk D, Crowl RM: Human HtrA, an evolutionarily conserved serine -protease identified as a differentially expressed gene product in osteoarthritic cartilage. J Biol Chem 1998; 273: 34406-34412.
26. Bakay M, Zhao P, Chen J, Hoffman EP. A web-accessible complete transcriptome of normal human and DMD muscle. Nouromuscul Disord 2002; 12 (Suppl 1): S125-S141.
27. Grau S, Baldi A, Bussani R, Tian X, Stefanescu R, Przybylski M et al Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proc Natl Acad Sci USA 2005; 102: 6021-6026.
28. Chien J, Staub J, Hu SI, Erickson-Johnson MR, Couch FJ, Smith DI et al. A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer. Oncogene 2004; 23: 1636-1644.
29. Shridhar V, Sen A, Chien J, Staub J, Avula R, Kovats S et al. Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. Cancer Res 2002; 62: 262-270.
30. Baldi A, De Luca A, Morini M, Battista T, Felsani A, Baldi F et al The HtrA1 serine protease is down-regulated during human melanoma progression and replesses growth of metastatic melanoma cells. Oncogene 2002; 21: 6684-6688.
31. Bowden MA, Di Nezza-Cossens LA, Jobling T, Salamonsen LA, Nie G. Serine proteases HTRA1 and HTRA3 are down-regulated with increasing grades of human endometrial cancer. Gynecol Oncol 2006; 103: 253-260.
32. Esposito V, Campioni M, De Luca A, Spugnini EP, Baldi F, Cassandro R et al. Analysis of HtrA1 serine protease expression in human lung cancer. Anticancer Res 2006; 26: 3455-3459.
33. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006; 314: 989-992.
34. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006; 314: 992-993.
35. Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D et al The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol 2007; 9: 1243-1252.
36. Gupta S, Singh R, Datta P, Zhang Z, Orr C, Lu Z et al. The C-terminal tail of presenilin regulates Orni/HtrA2 protease activity. J Biol Chem 2004; 279: 45844-45854.
37. Park HJ, Kim SS, Seong YM, Kim KH, Goo HG, Yoon EL et al. Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease: Implications for the physiological function of HtrA2 in the mitochondria. J Biol Chem 2006; 281: 34277-34287.
38. Huttunen HJ, Guenette SY, Peach C, Greco C, Xia W, Kim DY et al. HtrA2 regulates beta-amyloid precursor protein (APP) metabolism through endoplasmic reticulum-associated degradation. J Biol Chem 2007; 282: 28285-28295.
39. Beilina A, Van Der Brug M, Ahmad R, Kesavapany S, Miller DW, Petsko GA et al. Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc Natl Acad Sci USA 2005; 102: 5703-5708.
40. Sennvik K, Fastbom J, Blomberg M, Wahlund LO, Winblad B, Benedikz E. Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett 2000; 278: 169-172.
41. Tagawa K, Kunishita T, Maruyama K, Yoshikawa K, Kominami E, Tsuchiya T et al. Alzheimer's disease amyloid beta-clipping enzyme (APP secretase): Identification, purification, and characterization of the enzyme. Biochem Biophys Res Commun 1991; 177: 377-387.
42. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998; 391: 387-390.
43. Li J, Xu M, Zhou H, Ma J, Potter H. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 1997; 90: 917-927.
44. Kovacs DM, Fausett HJ, Page KJ, Kim TW, Moir RD, Merriam DE et al. Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat Med 1996; 2: 224-229.
45. Ankarcrona M, Hultenby K. Presenilin-1 is located in rat mitochondria. Biochem Biophys Res Commun 2002; 295: 766-770.
46. Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 2003; 161: 41-54.
47. Jin S, Kalkum M, Overholtzer M, Stoffel A, Chait BT, Levine AJ. CIAP1 and the serine protease HTRA2 are involved in a novel p53-dependent apoptosis pathway in mammals. Genes Dev 2003; 17: 359-367.
48. Martins LM, Turk BE, Cowling V, Borg A, Jarrell ET, Cantley LC et al Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Orni. J Biol Chem 2003; 278: 49417-49427.
49. Vande Walle L, Van Damme P, Lamkanfi M, Saelens X, Vandekerckhove J, Gevaert K et al. Proteome-wide identification of HtrA2/Orni substrates. J Proteome Res 2007; 6: 1006-1015.
50. Krojer T, Garrido-Franco M, Huber R, Ehrmann M, Clausen T. Crystal structure of DegP (HtrA) reveals a new protease-chaperone machine. Nature 2002; 416: 455-459.
51. Li W, Srinivasula SM, Chai J, Li P, Wu JW, Zhang Z et al. Structural insights into the proapoptotic function of mitochondrial serine protease HtrA2/Orni. Nat Struct Biol 2002; 9: 436-441.
52. Wilken C, Kitzing K, Kurzbauer R, Ehrmann M, Clausen T. Crystal structure of the DegS stress sensor: How a PDZ domain recognizes misfolded protein and activates a protease. Cell 2004; 117: 483-494.
53. Zeth K. Structural analysis of DegS, a stress sensor of the bacterial periplasm. FEBS Lett 2004; 569: 351-358.
54. Kim DY, Kim KK. Structure and function of HtrA family proteins, the key players in protein quality control. J Biochem Mol Biol 2005; 38 266-274.
55. Zhang Y, Appleton BA, Wu P, Wiesmann C, Sidhu SS. Structural and functional analysis of the ligand specificity of the HtrA2/Orni PDZ domain. Protein Sci 2007; 16: 1738-1750.
56. Cilenti L, Kyriazis GA, Soundarapandian MM, Stratico V, Yerkes A, Park KM et al. Orni/HtrA2 protease mediates cisplatin-induced cell death in renal cells. Am J Physiol Renal Physiol 2005: 288: F371-F379.
57. Kuninaka S, Nomura M, Hirota T, Iida S, Hara T, Honda S et al. The tumor suppressor WARTS activates the Orni/HtrA2-dependent pathway of cell death. Oncogene 2005; 24: 5287-5298.
58. Yang QH, Church-Hajduk R, Ren J, Newton ML, Du C. Orni/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev 2003; 17: 1487-1496.
59. Srinivasula SM, Gupta S, Datta P, Zhang Z, Hegde R, Cheong N et al Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Orni/HtrA2. J Biol Chem 2003; 278: 31469-31472.
60. Liu Z, Li H, Derouet M, Berezkin A, Sasazuki T, Shirasawa S et al. Oncogenic Ras inhibits anolkis of intestinal epithelial cells by preventing the release of a mitochondrial proapoptotic protein Orni/ HtrA2 into the cytoplasm. J Biol Chem 2006; 281: 14738-14747.
61. Cilenti L, Lee Y, Hess S, Srinivasula S, Park KM, Junqueira D et al Characterization of a novel and specific Inhibitor for the pro-apoptotic protease Orni/HtrA2. J Biol Chem 2003; 276: 11489-11494.
62. Cilenti L, Soundarapandian MM, Kyriazis GA, Stratico V, Singh S, Gupta S et al. Regulation of HAX-1 anti-apoptotic protein by Orni/HtrA2 protease during cell death. J Biol Chem 2004; 279: 50295-50301.
63. Blink E, Maianski NA, Alnemri ES, Zervos AS, Roos D, Kuijpers TW. Intramitochondrial serine protease activity of Orni/HtrA2 is required for caspase-independent cell death of human neutrophils. Cell Death Differ 2004; 11: 937-939.
64. Klupsch K, Downward J. The protease inhibitor Ucf-101 induces cellular responses independently of its known target, HtrA2/Orni. Cell Death Differ 2006; 13: 2157-2159.
65. Liu HR, ?o E, Hu A, Tao L, Qu Y, Most P et al. Role of Orni/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion. Circulation 2005; 111: 90-96.
66. Verhagen AM, Kratina TK, Hawkins CJ, Silke J, Ekert PG, Vaux DL. Identification of mammalian mitochondrial proteins that interact with IAPs via N-terminal IAP binding motifs. Cell Death Differ 2007; 14: 348-357.
67. Fraser AG, James C, Evan GI, Hengartner MO. Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr Biol 1999; 9: 292-301.
68. Speliotes EK, Uren A, Vaux D, Horvitz HR. The survivin-like C. elegans BIR-1 protein acts with the Aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone. Mol Cell 2000; 6 211-223.
69. Eckelman BP, Salvesen GS, Scott FL. Human inhibitor of apoptosis proteins: Why XIAP is the black sheep of the family. EMBO Rep 2006; 7: 988-994.
70. Eckelman BP, Salvesen GS, The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem 2006; 281 3254-3260.
71. Vaux DL, Silke J. IAPs - ubiquitin connection. Cell Death Differ 2005:12 1205-1207.
72. Wright CW, Duckett CS. Reawakening the cellular death program in noeplasia through the therapeutic blockade of IAP function. J Clin Invest 2005; 115: 2673-2678.
73. Schimmer AD, Dalili S. Targeting the IAP family of caspase inhibitors as an emerging therapeutic strategy. Hematology Am Soc Hematol Educ Program 2005; 1: 215-219.
74. Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB. Characterization of XIAP-deficient mice. Mol Cell Biol 2001; 21 3604-3608.
75. Olayioye MA, Kaufmann H, Pakusch M, Vaux DL, Lindeman GJ, Vistader JE. XIAP-deficiency leads to delayed lobuloalveolar developeent in the mammary gland. Cell Death Differ 2005; 12: 87-90.
76. Potts PR, Singh S, Knezek M, Thompson CB; Deshmukin M. Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis. J Cell Biol 2003; 163: 789-709.
77. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM Reid GE et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000; 102: 43-53.
78. Du C, Fang M, Li Y, U L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 2000; 102: 33-42.
79. Hegde R, Srinivasula SM, Datta P, Madesh M, Wassaell R, Zhang Z et al. The pollypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein. J Biol Chem 2003; 278: 38699-38706.
80. Hell K, Saleh M, Crescenzo GD, O'Connor-McCourt MD. Nicholson DW. Substrate cleavage by caspasds generates rotein fragments with Smac(Diablo-like activities. Cell Death Differ 2003; 10: 1234-1239.
81. Angell JE, Lindner DJ, Shapiro PS, Hofman ER, Kalvakolanu DV. Identification of GRIM-19, novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach. J Biol Chem 2000; 275: 33416-33426.
82. Ma X, Kalakonda S, Srinivasula SM, Reddy SP, Platanias LC, Kalvakolanu DV. GRIM-19 associates with the serine protease HA2 for promoting cell death. Oncogene 2007; 26: 4842-4849.
83. Feamley IM, Carroll J, Shannon RJ, Runswick, MJ, Walker JE, Hirst J. GRIM-19, a cell death regulatory gene product, is a subunit of bovine mitochondrial NADH:uBiguinone oxidoreductase (complex 1). J Biol Chem 2001; 276: 38345-38348.
84. Huang G, Lu H, Hao, A, Ng DC, Ponniah S. Guo K et al; GRIM-19, a cell death regulatory protein, is essential for assembly function of mitochondrial complex 1. Mol Cell Biol, 2004; 24: 8447-8456.
85. Trends A, Fiory F, Maitan MA, Vito P, Barbagallo AP, Perfetti A et al. Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15. J Biol Chem 2004; 279: 46566-46572.
86. Yang L, Sun M, Sun XM, Cheng GZ, Nicosia SV, Cheng JQ. Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212. J Biol Chem 2007; 282: 10981-10987.
87. Du K, Montminy M. CREB is a regulatory target for the protein kinase, Akt/PKB. J Biol Chem 1998; 273: 32377-32379.
88. Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE et al. Akt/protein kinass B up-regulates Bc1-2 expression through cAMP-response element-binding protein. J Biol Chem 2000; 275: 10761-10766.
89. Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 1699; 286: 2358-2361.
90. Wang JM; Chao JR, Chen W, Kuo ML, Yen JJ, Yang-Yen HF. The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol Cell Biol 1999; 19: 6195-6206.
91. Cardone MH, Roy N, Stennicke H.R, Salvesen GS, Franko TF, Stanbridge E et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998; 282: 1318-1321.
92. Gardai SJ, Hildeman DA, Frankel SK, Whitlock BB, Frasch SC, Borregaard, N et al. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 2004; 279 21085-21095.
93. Xin M, Dong X. Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem 2005; 280; 10781-10789.
94. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231-241.
95. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997; 278: 687-689.
96. Clemens MJ, Bushell M, Jeffrey IW, Pain VM, Morley SJ. Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ 2000; 7: 603-615.
97. Saelens X, Kalai M, Vandenabeele P. Translation inhibition in apoptosis: caspase-dependent PKA activation and elF2-alpha phosphorylation. J Biol.Chem 2001; 276: 41620-41628.
98. Breckenridge DG; Nguyen M, Kuppig S, Reth M, Shore GC. The procaspase-8 isoform, procaspase-8L,.recruited to the BAP31 complex at the endoplasmic reticulum. Proc Natl Acad Sci USA 2002; 99: 4331-4336.
99. Sundararajan R, Chen G, Mukherjee C, White E. Caspase-dapendent processing activates the proapoptotic activity of deleted in breast cancer-1 during tumor necrosis factor-alpha-mediated death signaling. Oncogene 2005; 24: 4908-4920.